Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 2,103: Line 2,103:
|
|
|
|
|}<br />
==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
{| class="wikitable"
|-
|-
| || ||
!'''Disease'''!!'''Page Type'''!!'''Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
| ||
!'''Date Completed by Author'''!!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|
!'''Notes'''
|-
|-
| || ||
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|2/20/2022
|
|
|PENDING
|
|
|
|Alanna Church
| ||
|
|
|
|
|-
|-
| || ||
|}<br />
|
 
|
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
|
{| class="wikitable"
| ||
|-
|
!'''Disease'''!!'''Page Type'''!!'''Author'''
|
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
| || ||
|Astrocystoma, IDH-Mutant
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
| ||
|2021 template added
|
|
|-
|-
| || ||
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
| ||
|2021 template added
|-
|Glioblastoma, IDH-Wildtype||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||
|
|
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|-
|Angiocentric Glioma||Disease||
|
|
|
|
| ||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
|Diffuse Midline Glioma, H3  K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|
|
|
|
|PENDING
|
|
| ||
|LS
|
|
|2021 template added
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|2/21/2022
|
|
|-
|PENDING
| || ||
|
|
|LS
|
|
|2021 template added
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|10/28/2022
|
|
| ||
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|-
| || ||
|Infant-Type Hemispheric Glioma||Disease||
|
|
|
|
|
|
| ||
|
|
|
|
|}<br />
|
 
|2021 template added
==WHO Classification of Soft Tissue and Bone Tumours (5th Edition) Content==
{| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
!'''Date Assigned to Author'''
|9/13/2022<br />
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|PENDING
!'''Date Completed by Author'''!!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|LS
!'''Notes'''
|
|2021 template added
|-
|-
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
|High-Grade Astrocytoma with Piloid Features||Disease||
|2/20/2022
|
|
|
|
|
|PENDING
|
|
|Alanna Church
|
|
|
|
|-
|-
|}<br />
|Pleomorphic Xanthoastrocytoma||Disease||
 
|
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Astrocystoma, IDH-Mutant
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
|2021 template added
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|3/3/2022
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||
|Subependymal Giant Cell Astrocytoma||Disease||
|
|
|
|
Line 2,279: Line 2,275:
|
|
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||
|Chordoid Glioma||Disease||
|
|
|
|
Line 2,288: Line 2,284:
|
|
|-
|-
|Angiocentric Glioma||Disease||
|Astroblastoma, MN1-Altered||Disease||
|
|
|
|
Line 2,297: Line 2,293:
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|Ganglioglioma||Disease||Leila Moayed-Aloei
|6/30/2022
|
|COMPLETE
|
|LS
|
|2021 template added
|-
|Gangliocytoma||Disease||
|
|
|
|
Line 2,306: Line 2,311:
|
|
|-
|-
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|
|
|
|
Line 2,315: Line 2,320:
|
|
|-
|-
|Diffuse Midline Glioma, H3  K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|
|
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|2/21/2022
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|10/28/2022
|
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|Infant-Type Hemispheric Glioma||Disease||
|
|
|
|
|
|-
|Papillary Glioneuronal Tumour||Disease||
|
|
|
|
|
|
|
|
|2021 template added
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|9/13/2022<br />
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|Rosette-Forming Glioneuronal Tumour||Disease||
|
|
|
|
Line 2,369: Line 2,356:
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|Myxoid Glioneuronal Tumour||Disease||
|
|
|
|
Line 2,378: Line 2,365:
|
|
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|
|
|
|
Line 2,387: Line 2,374:
|
|
|-
|-
|Chordoid Glioma||Disease||
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|
|
|
|
Line 2,396: Line 2,383:
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|
|
|
|
Line 2,405: Line 2,392:
|
|
|-
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|Central Neurocytoma||Disease||
|6/30/2022
|
|COMPLETE
|
|LS
|
|2021 template added
|-
|Gangliocytoma||Disease||
|
|
|
|
Line 2,423: Line 2,401:
|
|
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
|Extraventricular Neurocytoma||Disease||
|
|
|
|
Line 2,432: Line 2,410:
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|Cerebellar Liponeurocytoma||Disease||
|
|
|
|
Line 2,441: Line 2,419:
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|Supratentorial Ependymoma||Disease||
|
|
|
|
Line 2,450: Line 2,428:
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
Line 2,459: Line 2,437:
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
Line 2,468: Line 2,446:
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
|Posterior Fossa Ependymoma||Disease||
|
|
|
|
Line 2,477: Line 2,455:
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|
|
|
|
Line 2,486: Line 2,464:
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|
|
|
|
Line 2,495: Line 2,473:
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|Spinal Ependymoma||Disease||
|
|
|
|
Line 2,504: Line 2,482:
|
|
|-
|-
|Central Neurocytoma||Disease||
|Spinal Ependymoma, MYCN-Amplified||Disease||
|
|
|
|
Line 2,513: Line 2,491:
|
|
|-
|-
|Extraventricular Neurocytoma||Disease||
|Myxopapillary Ependymoma||Disease||
|
|
|
|
Line 2,522: Line 2,500:
|
|
|-
|-
|Cerebellar Liponeurocytoma||Disease||
|Subependymoma||Disease||
|
|
|
|
Line 2,531: Line 2,509:
|
|
|-
|-
|Supratentorial Ependymoma||Disease||
|Choroid Plexus Papilloma||Disease||
|
|
|
|
Line 2,540: Line 2,518:
|
|
|-
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
Line 2,549: Line 2,527:
|
|
|-
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|Choroid Plexus Carcinoma||Disease||
|
|
|
|
Line 2,558: Line 2,536:
|
|
|-
|-
|Posterior Fossa Ependymoma||Disease||
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
Line 2,567: Line 2,554:
|
|
|-
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|
|
|
|
Line 2,576: Line 2,563:
|
|
|-
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
Line 2,585: Line 2,572:
|
|
|-
|-
|Spinal Ependymoma||Disease||
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
Line 2,594: Line 2,581:
|
|
|-
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
Line 2,603: Line 2,590:
|
|
|-
|-
|Myxopapillary Ependymoma||Disease||
|Cribriform Neuroepithelial Tumour||Disease||
|
|
|
|
Line 2,612: Line 2,599:
|
|
|-
|-
|Subependymoma||Disease||
|Embryonal Tumour with Multilayered Rosettes||Disease||
|
|
|
|
Line 2,621: Line 2,608:
|
|
|-
|-
|Choroid Plexus Papilloma||Disease||
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|
|
|
|
Line 2,630: Line 2,617:
|
|
|-
|-
|Atypical Choroid Plexus Papilloma||Disease||
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|
|
|
|
Line 2,639: Line 2,626:
|
|
|-
|-
|Choroid Plexus Carcinoma||Disease||
|CNS Embryonal Tumour NEC/NOS||Disease||
|
|
|
|
Line 2,648: Line 2,635:
|
|
|-
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|Pineocytoma||Disease||
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
Line 2,666: Line 2,644:
|
|
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
|
|
Line 2,675: Line 2,653:
|
|
|-
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|Pineoblastoma||Disease||
|
|
|
|
Line 2,684: Line 2,662:
|
|
|-
|-
|Medulloblastoma, Histologically Defined||Disease||
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
Line 2,693: Line 2,671:
|
|
|-
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|
|
|
|
Line 2,702: Line 2,680:
|
|
|-
|-
|Cribriform Neuroepithelial Tumour||Disease||
|Schwannoma||Disease||
|
|
|
|
Line 2,711: Line 2,689:
|
|
|-
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|Neurofibroma||Disease||
|
|
|
|
Line 2,720: Line 2,698:
|
|
|-
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|Perineurioma||Disease||
|
|
|
|
Line 2,729: Line 2,707:
|
|
|-
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|Hybrid Nerve Sheath Tumours||Disease||
|
|
|
|
Line 2,738: Line 2,716:
|
|
|-
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
Line 2,747: Line 2,725:
|
|
|-
|-
|Pineocytoma||Disease||
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
|
|
Line 2,756: Line 2,734:
|
|
|-
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
Line 2,765: Line 2,743:
|
|
|-
|-
|Pineoblastoma||Disease||
|Meningioma||Disease||
|
|
|
|
Line 2,774: Line 2,752:
|
|
|-
|-
|Papillary Tumour of the Pineal Region||Disease||
|Solitary Fibrous Tumour||Disease||
|
|
|
|
Line 2,783: Line 2,761:
|
|
|-
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
Line 2,792: Line 2,770:
|
|
|-
|-
|Schwannoma||Disease||
|Haemangioblastoma||Disease||
|
|
|
|
Line 2,801: Line 2,779:
|
|
|-
|-
|Neurofibroma||Disease||
|Rhabdomyosarcoma||Disease||
|
|
|
|
Line 2,810: Line 2,788:
|
|
|-
|-
|Perineurioma||Disease||
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|
|
|
|
Line 2,819: Line 2,797:
|
|
|-
|-
|Hybrid Nerve Sheath Tumours||Disease||
|CIC-Rearranged Sarcoma||Disease||
|
|
|
|
Line 2,828: Line 2,806:
|
|
|-
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
Line 2,837: Line 2,815:
|
|
|-
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|Ewing Sarcoma||Disease||
|
|
|
|
Line 2,846: Line 2,824:
|
|
|-
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
Line 2,855: Line 2,833:
|
|
|-
|-
|Meningioma||Disease||
|Chondrosarcoma||Disease||
|
|
|
|
Line 2,864: Line 2,842:
|
|
|-
|-
|Solitary Fibrous Tumour||Disease||
|Chordoma||Disease||
|
|
|
|
Line 2,873: Line 2,851:
|
|
|-
|-
|Haemangiomas and Vascular Malformations||Disease||
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
Line 2,882: Line 2,860:
|
|
|-
|-
|Haemangioblastoma||Disease||
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
Line 2,891: Line 2,869:
|
|
|-
|-
|Rhabdomyosarcoma||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
Line 2,900: Line 2,878:
|
|
|-
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
|
|
Line 2,909: Line 2,887:
|
|
|-
|-
|CIC-Rearranged Sarcoma||Disease||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
Line 2,918: Line 2,896:
|
|
|-
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
Line 2,927: Line 2,905:
|
|
|-
|-
|Ewing Sarcoma||Disease||
|MALT Lymphoma of the Dura||Disease||
|
|
|
|
Line 2,936: Line 2,914:
|
|
|-
|-
|Mesenchymal Chondrosarcoma||Disease||
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
Line 2,945: Line 2,923:
|
|
|-
|-
|Chondrosarcoma||Disease||
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||
|
|
|
|
Line 2,954: Line 2,932:
|
|
|-
|-
|Chordoma||Disease||
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
Line 2,963: Line 2,941:
|
|
|-
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|Erdheim-Chester Disease||Disease||
|
|
|
|
Line 2,972: Line 2,950:
|
|
|-
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|Rosai-Dorfman Disease||Disease||
|
|
|
|
Line 2,981: Line 2,959:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|Juvenile Xanthogranuloma||Disease||
|
|
|
|
Line 2,990: Line 2,968:
|
|
|-
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
Line 2,999: Line 2,977:
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|Histiocytic Sarcoma||Disease||
|
|
|
|
Line 3,008: Line 2,986:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|Germ Cell Tumours of the CNS||Disease||
|
|
|
|
Line 3,017: Line 2,995:
|
|
|-
|-
|MALT Lymphoma of the Dura||Disease||
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
Line 3,026: Line 3,004:
|
|
|-
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|Papillary Craniopharyngioma||Disease||
|
|
|
|
Line 3,035: Line 3,013:
|
|
|-
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
Line 3,044: Line 3,022:
|
|
|-
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
Line 3,053: Line 3,031:
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|Pituitary Blastoma||Disease||
|
|
|
|
Line 3,062: Line 3,040:
|
|
|-
|-
|Rosai-Dorfman Disease||Disease||
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
|
|
Line 3,071: Line 3,049:
|
|
|-
|-
|Juvenile Xanthogranuloma||Disease||
|Metastases to the Meninges||Disease||
|
|
|
|
Line 3,080: Line 3,058:
|
|
|-
|-
|Langerhans Cell Histiocytosis||Disease||
|Neurofibromatosis Type 1||Disease||
|
|
|
|
Line 3,089: Line 3,067:
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|Neurofibromatosis Type 2||Disease||
|
|
|
|
Line 3,098: Line 3,076:
|
|
|-
|-
|Germ Cell Tumours of the CNS||Disease||
|Schwannomatosis||Disease||
|
|
|
|
Line 3,107: Line 3,085:
|
|
|-
|-
|Adamantinomatous Craniopharyngioma||Disease||
|Von Hippel-Lindau Syndrome||Disease||
|
|
|
|
Line 3,116: Line 3,094:
|
|
|-
|-
|Papillary Craniopharyngioma||Disease||
|Tuberous Sclerosis||Disease||
|
|
|
|
Line 3,125: Line 3,103:
|
|
|-
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|Li-Fraumeni Syndrome||Disease||
|
|
|
|
Line 3,134: Line 3,112:
|
|
|-
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|Cowden Syndrome||Disease||
|
|
|
|
Line 3,143: Line 3,121:
|
|
|-
|-
|Pituitary Blastoma||Disease||
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||
|
|
|
|
Line 3,152: Line 3,130:
|
|
|-
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|Familial Adenomatous Polyposis 1||Disease||
|
|
|
|
Line 3,161: Line 3,139:
|
|
|-
|-
|Metastases to the Meninges||Disease||
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
Line 3,170: Line 3,148:
|
|
|-
|-
|Neurofibromatosis Type 1||Disease||
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
|
|
|
Line 3,179: Line 3,157:
|
|
|-
|-
|Neurofibromatosis Type 2||Disease||
|Carney Complex||Disease||
|
|
|
|
Line 3,188: Line 3,166:
|
|
|-
|-
|Schwannomatosis||Disease||
|DICER1 Syndrome||Disease||
|
|
|
|
Line 3,197: Line 3,175:
|
|
|-
|-
|Von Hippel-Lindau Syndrome||Disease||
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
Line 3,206: Line 3,184:
|
|
|-
|-
|Tuberous Sclerosis||Disease||
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
Line 3,215: Line 3,193:
|
|
|-
|-
|Li-Fraumeni Syndrome||Disease||
|Familial Retinoblastoma||Disease||
|
|
|
|
Line 3,224: Line 3,202:
|
|
|-
|-
|Cowden Syndrome||Disease||
|BAP1 Tumour Predisposition Syndrome||Disease||
|
|
|
|
Line 3,233: Line 3,211:
|
|
|-
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||
|Fanconi Anaemia||Disease||
|
|
|
|
Line 3,242: Line 3,220:
|
|
|-
|-
|Familial Adenomatous Polyposis 1||Disease||
|ELP1-Medulloblastoma Syndrome||Disease||
|
|
|
|
Line 3,251: Line 3,229:
|
|
|-
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|}<br />
|
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
|
{| class="wikitable"
|
|-
|
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Adenoid Cystic Carcinoma
|Disease||Katherine Geiersbach
|10/12/02022
|
|
|PENDING
|
|
|Hui Chen
|
|
|2021 template added
|-
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|Secretory Carcinoma
|Disease
|Hui Chen
|10/12/2022
|
|PENDING
|
|Katherine Geiersbach
|
|2021 template added
|-
|}<br />
 
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|
|
|
|
Line 3,269: Line 3,283:
|
|
|-
|-
|Carney Complex||Disease||
|Columnar Cell Lesions, Including Flat Epithelial Atypia||Disease||
|
|
|
|
Line 3,278: Line 3,292:
|
|
|-
|-
|DICER1 Syndrome||Disease||
|Atypical Ductal Hyperplasia||Disease||
|
|
|
|
Line 3,287: Line 3,301:
|
|
|-
|-
|Familial Paraganglioma Syndromes||Disease||
|Sclerosing Adenosis||Disease||
|
|
|
|
Line 3,296: Line 3,310:
|
|
|-
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|Apocrine Adenosis and Adenoma||Disease||
|
|
|
|
Line 3,305: Line 3,319:
|
|
|-
|-
|Familial Retinoblastoma||Disease||
|Microglandular Adenosis||Disease||
|
|
|
|
Line 3,314: Line 3,328:
|
|
|-
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|Radial Scar/Complex Sclerosing Lesion||Disease||
|
|
|
|
Line 3,323: Line 3,337:
|
|
|-
|-
|Fanconi Anaemia||Disease||
|Tubular Adenoma||Disease||
|
|
|
|
Line 3,332: Line 3,346:
|
|
|-
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|Lactating Adenoma||Disease||
|
|
|
|
Line 3,341: Line 3,355:
|
|
|-
|-
|}<br />
|Ductal Adenoma||Disease||
==WHO Classification of Tumours of Breast Tumours (5th Edition) Content==
|
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Adenoid Cystic Carcinoma
|Disease||Katherine Geiersbach
|10/12/02022
|
|
|PENDING
|
|
|Hui Chen
|
|
|2021 template added
|-
|Secretory Carcinoma
|Disease
|Hui Chen
|10/12/2022
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|2021 template added
|-
|}<br />
==WHO Breast tumours  (5th ed.) Content==
{| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
|Pleomorphic Adenoma||Disease||
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|- |Usual ductal hyperplasia||Disease||
|
|
|
|
Line 3,395: Line 3,373:
|
|
|-
|-
|Columnar cell lesions, including flat epithelial atypia||Disease||
|Adenomyoepithelioma||Disease||
|
|
|
|
Line 3,404: Line 3,382:
|
|
|-
|-
|Atypical ductal hyperplasia||Disease||
|Malignant Adenomyoepithelioma||Disease||
|
|
|
|
Line 3,413: Line 3,391:
|
|
|-
|-
|Sclerosing adenosis||Disease||
|Intraductal Papilloma||Disease||
|
|
|
|
Line 3,422: Line 3,400:
|
|
|-
|-
|Apocrine adenosis and adenoma||Disease||
|Papillary Ductal Carcinoma In Situ||Disease||
|
|
|
|
Line 3,431: Line 3,409:
|
|
|-
|-
|Microglandular adenosis||Disease||
|Encapsulated Papillary Carcinoma||Disease||
|
|
|
|
Line 3,440: Line 3,418:
|
|
|-
|-
|Radial scar / complex sclerosing lesion||Disease||
|Solid Papillary Carcinoma (In Situ and Invasive)||Disease||
|
|
|
|
Line 3,449: Line 3,427:
|
|
|-
|-
|Tubular adenoma||Disease||
|Invasive Papillary Carcinoma||Disease||
|
|
|
|
Line 3,458: Line 3,436:
|
|
|-
|-
|Lactating adenoma||Disease||
|Atypical Lobular Hyperplasia||Disease||
|
|
|
|
Line 3,467: Line 3,445:
|
|
|-
|-
|Ductal adenoma||Disease||
|Lobular Carcinoma In Situ||Disease||
|
|
|
|
Line 3,476: Line 3,454:
|
|
|-
|-
|Pleomorphic adenoma||Disease||
|Ductal Carcinoma In Situ||Disease||
|
|
|
|
Line 3,485: Line 3,463:
|
|
|-
|-
|Adenomyoepithelioma||Disease||
|Invasive breast carcinoma: General overview||Disease||????
|
|
|
|
Line 3,494: Line 3,472:
|
|
|-
|-
|Malignant adenomyoepithelioma||Disease||
|Invasive Breast Carcinoma of No Special Type||Disease||
|
|
|
|
Line 3,503: Line 3,481:
|
|
|-
|-
|Intraductal papilloma||Disease||
|Microinvasive Carcinoma||Disease||
|
|
|
|
Line 3,512: Line 3,490:
|
|
|-
|-
|Papillary ductal carcinoma in situ||Disease||
|Invasive lobular Carcinoma||Disease||
|
|
|
|
Line 3,521: Line 3,499:
|
|
|-
|-
|Encapsulated papillary carcinoma||Disease||
|Tubular Carcinoma||Disease||
|
|
|
|
Line 3,530: Line 3,508:
|
|
|-
|-
|Solid papillary carcinoma (in situ and invasive)||Disease||
|Cribriform Carcinoma||Disease||
|
|
|
|
Line 3,539: Line 3,517:
|
|
|-
|-
|Invasive papillary carcinoma||Disease||
|Mucinous Carcinoma||Disease||
|
|
|
|
Line 3,548: Line 3,526:
|
|
|-
|-
|Atypical lobular hyperplasia||Disease||
|Mucinous Cystadenocarcinoma||Disease||
|
|
|
|
Line 3,557: Line 3,535:
|
|
|-
|-
|Lobular carcinoma in situ||Disease||
|Invasive Micropapillary Carcinoma||Disease||
|
|
|
|
Line 3,566: Line 3,544:
|
|
|-
|-
|Ductal carcinoma in situ||Disease||
|Carcinoma with Apocrine Differentiation||Disease||
|
|
|
|
Line 3,575: Line 3,553:
|
|
|-
|-
|Invasive breast carcinoma: General overview||Disease||
|Metaplastic Carcinoma||Disease||
|
|
|
|
Line 3,584: Line 3,562:
|
|
|-
|-
|Invasive breast carcinoma of no special type||Disease||
|Acinic Cell Carcinoma||Disease||
|
|
|
|
Line 3,593: Line 3,571:
|
|
|-
|-
|Microinvasive carcinoma||Disease||
|Adenoid Cystic Carcinoma||Disease||
|
|
|
|
Line 3,602: Line 3,580:
|
|
|-
|-
|Invasive lobular carcinoma||Disease||
|Secretory Carcinoma||Disease||
|
|
|
|
Line 3,611: Line 3,589:
|
|
|-
|-
|Tubular carcinoma||Disease||
|Mucoepidermoid Carcinoma||Disease||
|
|
|
|
Line 3,620: Line 3,598:
|
|
|-
|-
|Cribriform carcinoma||Disease||
|Polymorphous Adenocarcinoma||Disease||
|
|
|
|
Line 3,629: Line 3,607:
|
|
|-
|-
|Mucinous carcinoma||Disease||
|Tall Cell Carcinoma with Reversed Polarity||Disease||
|
|
|
|
Line 3,638: Line 3,616:
|
|
|-
|-
|Mucinous cystadenocarcinoma||Disease||
|Neuroendocrine Tumour||Disease||
|
|
|
|
Line 3,647: Line 3,625:
|
|
|-
|-
|Invasive micropapillary carcinoma||Disease||
|Neuroendocrine Carcinoma||Disease||
|
|
|
|
Line 3,656: Line 3,634:
|
|
|-
|-
|Carcinoma with apocrine differentiation||Disease||
|Hamartoma||Disease||
|
|
|
|
Line 3,665: Line 3,643:
|
|
|-
|-
|Metaplastic carcinoma||Disease||
|Fibroadenoma||Disease||
|
|
|
|
Line 3,674: Line 3,652:
|
|
|-
|-
|Acinic cell carcinoma||Disease||
|Phyllodes Tumour||Disease||
|
|
|
|
Line 3,683: Line 3,661:
|
|
|-
|-
|Adenoid cystic carcinoma||Disease||
|Syringomatous Tumour||Disease||
|
|
|
|
Line 3,692: Line 3,670:
|
|
|-
|-
|Secretory carcinoma||Disease||
|Nipple Adenoma||Disease||
|
|
|
|
Line 3,701: Line 3,679:
|
|
|-
|-
|Mucoepidermoid carcinoma||Disease||
|Paget disease of the Breast||Disease||
|
|
|
|
Line 3,710: Line 3,688:
|
|
|-
|-
|Polymorphous adenocarcinoma||Disease||
|Haemangioma||Disease||
|
|
|
|
Line 3,719: Line 3,697:
|
|
|-
|-
|Tall cell carcinoma with reversed polarity||Disease||
|Angiomatosis||Disease||
|
|
|
|
Line 3,728: Line 3,706:
|
|
|-
|-
|Neuroendocrine tumour||Disease||
|Atypical Vascular Lesions||Disease||
|
|
|
|
Line 3,737: Line 3,715:
|
|
|-
|-
|Neuroendocrine carcinoma||Disease||
|Postradiation Angiosarcoma of the Breast||Disease||
|
|
|
|
Line 3,746: Line 3,724:
|
|
|-
|-
|Hamartoma||Disease||
|Primary Angiosarcoma of the Breast||Disease||
|
|
|
|
Line 3,755: Line 3,733:
|
|
|-
|-
|Fibroadenoma||Disease||
|Nodular Fasciitis||Disease||
|
|
|
|
Line 3,764: Line 3,742:
|
|
|-
|-
|Phyllodes tumour||Disease||
|Myofibroblastoma||Disease||
|
|
|
|
Line 3,773: Line 3,751:
|
|
|-
|-
|Syringomatous tumour||Disease||
|Desmoid Fibromatosis||Disease||
|
|
|
|
Line 3,782: Line 3,760:
|
|
|-
|-
|Nipple adenoma||Disease||
|Inflammatory Myofibroblastic Tumour||Disease||
|
|
|
|
Line 3,791: Line 3,769:
|
|
|-
|-
|Paget disease of the breast||Disease||
|Schwannoma||Disease||
|
|
|
|
Line 3,800: Line 3,778:
|
|
|-
|-
|Haemangioma||Disease||
|Neurofibroma||Disease||
|
|
|
|
Line 3,809: Line 3,787:
|
|
|-
|-
|Angiomatosis||Disease||
|Granular Cell Tumour||Disease||
|
|
|
|
Line 3,818: Line 3,796:
|
|
|-
|-
|Atypical vascular lesions||Disease||
|Leiomyoma||Disease||
|
|
|
|
Line 3,827: Line 3,805:
|
|
|-
|-
|Postradiation angiosarcoma of the breast||Disease||
|Leiomyosarcoma||Disease||
|
|
|
|
Line 3,836: Line 3,814:
|
|
|-
|-
|Primary angiosarcoma of the breast||Disease||
|Lipoma||Disease||
|
|
|
|
Line 3,845: Line 3,823:
|
|
|-
|-
|Nodular fasciitis||Disease||
|Angiolipoma||Disease||
|
|
|
|
Line 3,854: Line 3,832:
|
|
|-
|-
|Myofibroblastoma||Disease||
|Liposarcoma||Disease||
|
|
|
|
Line 3,863: Line 3,841:
|
|
|-
|-
|Desmoid fibromatosis||Disease||
|Pseudoangiomatous Stromal Hyperplasia||Disease||
|
|
|
|
Line 3,872: Line 3,850:
|
|
|-
|-
|Inflammatory myofibroblastic tumour||Disease||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||
|
|
|
|
Line 3,881: Line 3,859:
|
|
|-
|-
|Schwannoma||Disease||
|Follicular Lymphoma||Disease||
|
|
|
|
Line 3,890: Line 3,868:
|
|
|-
|-
|Neurofibroma||Disease||
|Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
Line 3,899: Line 3,877:
|
|
|-
|-
|Granular cell tumour||Disease||
|Burkitt Lymphoma||Disease||
|
|
|
|
Line 3,908: Line 3,886:
|
|
|-
|-
|Leiomyoma||Disease||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
Line 3,917: Line 3,895:
|
|
|-
|-
|Leiomyosarcoma||Disease||
|Gynaecomastia||Disease||
|
|
|
|
Line 3,926: Line 3,904:
|
|
|-
|-
|Lipoma||Disease||
|Carcinoma In Situ||Disease||
|
|
|
|
Line 3,935: Line 3,913:
|
|
|-
|-
|Angiolipoma||Disease||
|Invasive Carcinoma||Disease||
|
|
|
|
Line 3,944: Line 3,922:
|
|
|-
|-
|Liposarcoma||Disease||
|Metastases to the Breast||Disease||
|
|
|
|
Line 3,953: Line 3,931:
|
|
|-
|-
|Pseudoangiomatous stromal hyperplasia||Disease||
|BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome||Disease||
|
|
|
|
Line 3,962: Line 3,940:
|
|
|-
|-
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease||
|Cowden Syndrome||Disease||
|
|
|
|
Line 3,971: Line 3,949:
|
|
|-
|-
|Follicular lymphoma||Disease||
|Ataxia-Telangiectasia||Disease||
|
|
|
|
Line 3,980: Line 3,958:
|
|
|-
|-
|Diffuse large B-cell lymphoma||Disease||
|Li-Fraumeni Syndrome, TP53-Associated||Disease||
|
|
|
|
Line 3,989: Line 3,967:
|
|
|-
|-
|Burkitt lymphoma||Disease||
|Li-Fraumeni Syndrome, CHEK2-Associated||Disease||
|
|
|
|
Line 3,998: Line 3,976:
|
|
|-
|-
|Breast implant-associated anaplastic large cell lymphoma||Disease||
|CDH1-Associated Breast Cancer||Disease||
|
|
|
|
Line 4,007: Line 3,985:
|
|
|-
|-
|Gynaecomastia||Disease||
|PALB2-Associated Cancers||Disease||
|
|
|
|
Line 4,016: Line 3,994:
|
|
|-
|-
|Carcinoma in situ||Disease||
|Peutz-Jeghers Syndrome||Disease||
|
|
|
|
Line 4,025: Line 4,003:
|
|
|-
|-
|Invasive carcinoma||Disease||
|Neurofibromatosis Type 1||Disease||
|
|
|
|
|
|
|
|-
|Metastases to the breast||Disease||
|
|
|
|
|
|
|
|-
|BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease||
|
|
|
|
|
|
|
|-
|Cowden syndrome||Disease||
|
|
|
|
|
|
|
|-
|Ataxia-telangiectasia||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni syndrome, TP53-associated||Disease||
|
|
|
|
|
|
|
|-
|Li-Fraumeni syndrome, CHEK2-associated||Disease||
|
|
|
|
|
|
|
|-
|CDH1-associated breast cancer||Disease||
|
|
|
|
|
|
|
|-
|PALB2-associated cancers||Disease||
|
|
|
|
|
|
|
|-
|Peutz-Jeghers syndrome||Disease||
|
|
|
|
|
|
|
|-
|Neurofibromatosis type 1||Disease||
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"